Cardiac scintigraphy for transthyretin amyloidosis: a decade of progress, a future of precision
- PMID: 40590727
- DOI: 10.2459/JCM.0000000000001753
Cardiac scintigraphy for transthyretin amyloidosis: a decade of progress, a future of precision
References
-
- Nativi-Nicolau J, Siu A, Dispenzieri A, Maurer MS, Rapezzi C, Kristen AV, et al. Temporal trends of wild-type transthyretin amyloid cardiomyopathy in the transthyretin amyloidosis outcomes survey. JACC CardioOncol 2021; 3:537–546.
-
- Longhi S, Biagini E, Guaraldi P, Carigi S, Dossi MC, Bartolotti M, et al. Temporal implementation of a regional referral pathway in transthyretin cardiac amyloidosis: Emilia-Romagna experience. J Cardiovasc Med 2024; 25:682–692.
-
- Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, et al. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation 2016; 133:2404–2412.
-
- Ahluwalia N, Roshankar G, Draycott L, Jimenez-Zepeda V, Fine N, Chan D, et al. Diagnostic accuracy of bone scintigraphy imaging for transthyretin cardiac amyloidosis: systematic review and meta-analysis. J Nucl Cardiol 2023; 30:2464–2476.
-
- Porcari A, Razvi Y, Cappelli F, Nitsche C, Serenelli M, Longhi S, et al. Clinical phenotype and prognosis of asymptomatic patients with transthyretin cardiac amyloid infiltration. JAMA Cardiol 2025; 10:437–445.
LinkOut - more resources
Full Text Sources
Research Materials
